Brief: Chemometec H1 EBITDA DKK 135.2 Million
Feb 05 (Reuters) - Chemometec H1 EBITDA margin 54%. * H1 revenue DKK 251.5 million * outlook FY EBITDA DKK 250-260 million
Feb 05 (Reuters) - Chemometec H1 EBITDA margin 54%. * H1 revenue DKK 251.5 million * outlook FY EBITDA DKK 250-260 million